Literature DB >> 15883311

MRI predictors of risk of incident Alzheimer disease: a longitudinal study.

T R Stoub1, M Bulgakova, S Leurgans, D A Bennett, D Fleischman, D A Turner, L deToledo-Morrell.   

Abstract

OBJECTIVE: To determine if baseline entorhinal and hippocampal volumes and their rate of atrophy could predict the risk of incident Alzheimer disease (AD).
METHODS: The authors used proportional odds models to assess the relationship between entorhinal and hippocampal size and risk of incident AD among 58 nondemented elderly people. All participants were followed with annual clinical evaluations and structural MRI scans for up to 5 years (baseline and 5 years of follow-up). At baseline, 23 of 58 participants received a diagnosis of amnestic mild cognitive impairment (MCI) and 35 of 58 were healthy control subjects with no cognitive impairment. Structural MRI scans were acquired with a T1-weighted three-dimensional spoiled gradient-recalled echo pulse sequence in a 1.5 T scanner. Entorhinal and hippocampal volumes were derived from 1.6-mm gapless coronal images reformatted to be perpendicular to the long axis of the hippocampus and were normalized by dividing with intracranial volume.
RESULTS: Fourteen of 58 nondemented participants developed AD during the follow-up period. Initial diagnosis of MCI was a significant predictor of incident AD. In addition, both baseline entorhinal volume and its slope of decline were independent predictors of incident AD, but initial hippocampal size and its rate of decline were not, after controlling for entorhinal volume.
CONCLUSION: In nondemented individuals, entorhinal cortex atrophy is associated with risk of Alzheimer disease.

Entities:  

Mesh:

Year:  2005        PMID: 15883311     DOI: 10.1212/01.WNL.0000160089.43264.1A

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  83 in total

Review 1.  Mild cognitive impairment: pathology and mechanisms.

Authors:  Elliott J Mufson; Lester Binder; Scott E Counts; Steven T DeKosky; Leyla de Toledo-Morrell; Stephen D Ginsberg; Milos D Ikonomovic; Sylvia E Perez; Stephen W Scheff
Journal:  Acta Neuropathol       Date:  2011-11-19       Impact factor: 17.088

2.  Selective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of Alzheimer's disease.

Authors:  Leonel E Rojo; Jans Alzate-Morales; Iván N Saavedra; Peter Davies; Ricardo B Maccioni
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 3.  Selected findings from the Religious Orders Study and Rush Memory and Aging Project.

Authors:  David A Bennett; Robert S Wilson; Zoe Arvanitakis; Patricia A Boyle; Leyla de Toledo-Morrell; Julie A Schneider
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

4.  MRI hippocampal and entorhinal cortex mapping in predicting conversion to Alzheimer's disease.

Authors:  D P Devanand; Ravi Bansal; Jun Liu; Xuejun Hao; Gnanavalli Pradhaban; Bradley S Peterson
Journal:  Neuroimage       Date:  2012-01-25       Impact factor: 6.556

5.  Hippocampal disconnection contributes to memory dysfunction in individuals at risk for Alzheimer's disease.

Authors:  Travis R Stoub; Leyla deToledo-Morrell; Glenn T Stebbins; Sue Leurgans; David A Bennett; Raj C Shah
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-19       Impact factor: 11.205

6.  Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer's disease, mild cognitive impairment and elderly controls.

Authors:  Yi-Yu Chou; Natasha Leporé; Christina Avedissian; Sarah K Madsen; Neelroop Parikshak; Xue Hua; Leslie M Shaw; John Q Trojanowski; Michael W Weiner; Arthur W Toga; Paul M Thompson
Journal:  Neuroimage       Date:  2009-02-21       Impact factor: 6.556

7.  Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease.

Authors:  John C Morris; Catherine M Roe; Elizabeth A Grant; Denise Head; Martha Storandt; Alison M Goate; Anne M Fagan; David M Holtzman; Mark A Mintun
Journal:  Arch Neurol       Date:  2009-12

8.  fMRI activation changes during successful episodic memory encoding and recognition in amnestic mild cognitive impairment relative to cognitively healthy older adults.

Authors:  Mehul A Trivedi; Christopher M Murphy; Celine Goetz; Raj C Shah; John D E Gabrieli; Susan Whitfield-Gabrieli; David A Turner; Glenn T Stebbins
Journal:  Dement Geriatr Cogn Disord       Date:  2008-07-28       Impact factor: 2.959

9.  In vivo hippocampal subfield shape related to TDP-43, amyloid beta, and tau pathologies.

Authors:  Veronika Hanko; Alexandra C Apple; Kathryn I Alpert; Kristen N Warren; Julie A Schneider; Konstantinos Arfanakis; David A Bennett; Lei Wang
Journal:  Neurobiol Aging       Date:  2018-10-25       Impact factor: 4.673

Review 10.  Current and future uses of neuroimaging for cognitively impaired patients.

Authors:  Gary W Small; Susan Y Bookheimer; Paul M Thompson; Greg M Cole; S-C Huang; Vladimir Kepe; Jorge R Barrio
Journal:  Lancet Neurol       Date:  2008-02       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.